Syncom Formulations Limited Share Price Target 2025, 2030, 2035, 2040, 2045, 2050
Invest In, Stocks, Technical Analysis
Syncom Formulations Limited: A Comprehensive Overview
The Syncom Formulations Limited is one of the crucial stakeholders in India’s pharmaceutical markets, with an aim of providing quality heath care services. Analyzing the services and products which Syncom has to offer, the quality of services, the market segment it covers the financial perspective of Syncom and finally the long term forecast of share price for Syncom will be beneficial for investors and stakeholders.
Table of Contents
- A Brief History
- Products and Services
- Commitment to Quality
- Market Presence
- Financial Performance
- Future Prospects
- Syncom Formulations Share Price Targets (2024-2050)
- Share Price Forecasts (2024-2030)
- Long-Term Predictions (2035-2050)
- Fundamental Analysis
- Shareholding Pattern
- FAQs
- What is The Syncom Formulations Share Price Prediction 2025?
- What is The Syncom Formulations Share Price Prediction 2026?
- What is The Syncom Formulations Share Price Prediction 2027?
- What is The Syncom Formulations Share Price Prediction 2028?
- What is The Syncom Formulations Share Price Prediction 2029?
- What is The Syncom Formulations Share Price Prediction 2030?
- What is The Syncom Formulations Share Price Prediction 2035?
- What is The Syncom Formulations Share Price Prediction 2040?
- What is The Syncom Formulations Share Price Prediction 2050?
- Conclusion
- Disclaimer
A Brief History
Syncom Formulations Limited is a growing company that has emerged in India since the beginning of the 1990s. Principal activity: Intense on research and development, the company went a notch higher bringing quality pharmaceutical products to the international market.
Products and Services
Syncom Formulations Limited offers a diverse portfolio of pharmaceutical products, including:
- Tablets and Capsules
It can be prescribed for pain relief, infections, and long-term illness. - Injectables
Special product designs for the intensive care and immediate care environment. - Syrups and Suspensions
Medicines have the added feature of being easily taken especially when they have reached their weaning period.
Commitment to Quality
Syncom Formulations Limited places a strong emphasis on maintaining high standards of quality, reflected in its certifications:
- WHO Certification: Keeps products safe for use and to customers and patient and effective.
- GMP Certification: Ensures compliance to GMP to facilitate a consistent product quality.
Market Presence
Today, Syncom Formulations Limited has a diverse distribution network in the domestic as well as the global marketplace and it works with hospitals and distributors worldwide to make its products easily available to everyone.
Financial Performance
Being a listed company, the Syncom Formulations proves that it has stabilized its financial parameters. For this reason, the performance of the company has been steady due to the commitment of new approaches in delivery of its goods and services and quality.
Future Prospects
Syncom Formulations aims to drive growth through:
- Entrepreneurial orientation in terms of adopting high levels of technological innovation.
- Venturing into currently unexplored markets for the firm.
- Expanding human resource development to produce customers oriented products.
Syncom Formulations Share Price Targets (2024-2050)
Share Price Forecasts (2024-2030)
| Year | Projected Price Range (₹) |
|---|---|
| 2024 | 11.70 – 26.80 |
| 2025 | 27.60 – 43.50 |
| 2026 | 45.75 – 72.87 |
| 2027 | 75.00 – 105.25 |
| 2028 | 108.50 – 150.00 |
| 2029 | 154.50 – 200.00 |
| 2030 | 205.00 – 260.50 |
Long-Term Predictions (2035-2050)
| Year | Projected Price Range (₹) |
|---|---|
| 2035 | 505.00 – 560.00 |
| 2040 | 805.00 – 860.00 |
| 2050 | 1,405.00 – 1,460.00 |
Fundamental Analysis
| Metric | Value |
|---|---|
| Market Cap | ₹2,187.38 Cr |
| Promoter Holding | 50.57% |
| Sales Growth | 2.27% |
| ROCE | 9.68% |
| Debt | ₹83.18 Cr |
| EPS (TTM) | ₹0.29 |
| P/E Ratio | 81 |
| Dividend Yield | 0% |
Shareholding Pattern
| Category | Percentage |
|---|---|
| Promoters | 50.57% |
| Retail & Others | 49.43% |
FAQs
1. Where does Syncom Formulations get its revenue from?
Syncom Formulations Limited therefore specialises in the production of pharmaceutical products such as tablets, injectables and syrups, among others.
2.Should I buy Syncom Formulations?
It’s important for long-term investors since it has presented a constant growth and is seeking to strengthen its position on the market. However, more research and analyst should be conducted before investing in any of the stocks.
3. Which certifications does Syncom possess?
Syncom also comply with WHO and GMP standard which assure the company of good quality production.
4. Where can I acquire Syncom Formulations shares?
To purchase the Syncom shares you can approach any of the NSE or BSE brokers to purchase at the respective stock exchange.
5. That leads to the next questions about the company regarding its future growth plans of Syncom?
With these objectives, the company wants to harness new technologies, enter new markets and scale up the company’s R&D.
What is The Syncom Formulations Share Price Prediction 2025?
The Syncom Formulations Share Price Prediction 2025 is 27.60 – 43.50INR.
What is The Syncom Formulations Share Price Prediction 2026?
The Syncom Formulations Share Price Prediction 2026 is 45.75 – 72.87INR.
What is The Syncom Formulations Share Price Prediction 2027?
The Syncom Formulations Share Price Prediction 2027 is 75.00 – 105.25INR.
What is The Syncom Formulations Share Price Prediction 2028?
The Syncom Formulations Share Price Prediction 2028 is 108.50 – 150.00INR.
What is The Syncom Formulations Share Price Prediction 2029?
The Syncom Formulations Share Price Prediction 2029 is 154.50 – 200.00INR.
What is The Syncom Formulations Share Price Prediction 2030?
The Syncom Formulations Share Price Prediction 2030 is 205.00 – 260.50INR.
What is The Syncom Formulations Share Price Prediction 2035?
The Syncom Formulations Share Price Prediction 2035 is 505.00 – 560.00INR.
What is The Syncom Formulations Share Price Prediction 2040?
The Syncom Formulations Share Price Prediction 2040 is 805.00 – 860.00INR.
What is The Syncom Formulations Share Price Prediction 2050?
The Syncom Formulations Share Price Prediction 2050 is 1,405.00 – 1,460.00INR.
Conclusion
This research work has further strengthened the findings to reveal Syncom Formulations Limited as a reliable and innovative pharma firm. Thanks to the clear long-term plan of development and due focus on high level of product quality, it is able to build a sustainable future in national and international contexts. To get the most current information visit the official website of the company or follow their financial statements.
Disclaimer
This article is not meant to be used as a source of financial advice or information. The projections and data are, to the extent, possible and reasonable, based on information that is publicly available and analysis. Prices in the stock market are volatile, and the past performance should not be a factor of predicting future results. Based on such a decision, one should seek the assistance of a financial expert before investing.
